Jiang Yizhou
Molecular classification and triple-negative breast cancer
Professor and breast-cancer specialist
Fudan University Shanghai Cancer CenterA member of the breast-cancer team at Fudan University Shanghai Cancer Center, with published work on breast-cancer subtypes and triple-negative disease.
Professional background
The hospital’s 2022 research report identifies him as a professor and describes his work in the breast-cancer team. Clinical use of a research approach requires individual assessment.
This introduction describes published professional work. The hospital confirms the current role, consultation language, appointment location and availability for your enquiry.
This information helps you prepare for a clinical conversation. It does not establish a diagnosis, treatment eligibility or a confirmed booking. A listed hospital or clinician is not a claim of partnership. Seek local urgent care for an emergency.
Sources and references
Related conditions and questions
Breast cancer
Breast cancer includes diseases with different stages and tumour characteristics. A breast-team review brings pathology, imaging and previous treatment together before discussing a plan.
Triple-negative breast cancer
Triple-negative breast cancer lacks the hormone-receptor and HER2 features used to select some breast-cancer treatments. The term does not by itself establish stage or an individual treatment plan.
Recurrent or metastatic breast cancer
Breast cancer may recur near the original site or spread to distant organs. These situations differ, so a review first clarifies where the disease is now and what treatment has already been used.
You don’t have to figure it out alone.
Tell us what you need help with. Your first conversation is free, and there’s no need to have every document ready.